Updated on 2024/10/07

Information

 

写真a

 
ITO TOMOYA
 
Organization
Faculty of Pharmaceutical Sciences Department of Pharmaceutical Health Care and Sciences Assistant Professor
School of Pharmaceutical Sciences Department of Clinical Pharmacy(Joint Appointment)
Graduate School of Pharmaceutical Sciences Department of Clinical Pharmacy(Joint Appointment)
Title
Assistant Professor
Contact information
メールアドレス
Tel
0926426585

Research Areas

  • Life Science / Molecular biology

Degree

  • Ph.D. (Life Science)

Research History

  • Kyushu University Graduate School of Pharmaceutical Sciences Assistant Professor

    2024.4 - Present

      More details

  • 2014.10 - 2014.12 東京工業大学 バイオ研究基盤支援総合センター 教育支援員 2015.01 - 2015.03 京都大学大学院工学研究科 合成・生物化学専攻 教務補佐員 2015.04 - 2016.09 自然科学研究機構生理学研究所 生体情報研究系 心循環シグナル研究部門 博士研究員(NIPS リサーチフェロー) 2016.10 - 2024.03 英国ロンドン大学クイーン・メアリー校ウィリアム・ハーベイ研究所 博士研究員

Papers

  • Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes. Reviewed

    Moe Kondo, Yuya Nakamura, Yuri Kato, Akiyuki Nishimura, Mitsuhiro Fukata, Shohei Moriyama, Tomoya Ito, Keitaro Umezawa, Yasuteru Urano, Takaaki Akaike, Koichi Akashi, Yasunari Kanda, Motohiro Nishida

    Journal of pharmacological sciences   156 ( 2 )   69 - 76   2024.10   ISSN:1347-8613 eISSN:1347-8648

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Despite the widespread recognition of the global concern regarding the onset of cardiovascular diseases in a significant number of patients following cancer treatment, definitive strategies for prevention and treatment remain elusive. In this study, we established systems to evaluate the influence of anti-cancer drugs on the quality control of mitochondria, pivotal for energy metabolism, using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Osimertinib, an epidermal growth factor receptor tyrosine kinase inhibitor used for treatment in lung cancer, reportedly increases the risk of cardiovascular disease. However, its underlying mechanism is largely unknown. Here, we found that the treatment of hiPSC-CMs with osimertinib and doxorubicin, but not trastuzumab and cisplatin, revealed a concentration-dependent impairment of respiratory function accompanied by mitochondrial fission. We previously reported the significant role of sulfur metabolism in maintaining mitochondrial quality in the heart. Co-treatment with various inorganic sulfur donors (Na2S, Na2S2, Na2S3) alongside anti-cancer drugs demonstrated that Na2S attenuated the cardiotoxicity of osimertinib but not doxorubicin. Osimertinib decreased intracellular reduced sulfur levels, while Na2S treatment suppressed the sulfur leakage, suggesting its potential in mitigating osimertinib-induced cardiotoxicity. These results imply the prospect of inorganic sulfides, such as Na2S, as a seed for precision pharmacotherapy to alleviate osimertinib's cardiotoxic effects.

    DOI: 10.1016/j.jphs.2024.07.007

    Web of Science

    Scopus

    PubMed

    researchmap

  • Supersulfide catabolism participates in maladaptive remodeling of cardiac cells. Reviewed

    Zhou L, Nishimura A, Umezawa K, Kato Y, Mi X, Ito T, Urano Y, Akaike T, Nishida M

    Journal of pharmacological sciences   155 ( 4 )   121 - 130   2024.8   ISSN:1347-8613 eISSN:1347-8648

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The atrophic myocardium resulting from mechanical unloading and nutritional deprivation is considered crucial as maladaptive remodeling directly associated with heart failure, as well as interstitial fibrosis. Conversely, myocardial hypertrophy resulting from hemodynamic loading is perceived as compensatory stress adaptation. We previously reported the abundant presence of highly redox-active polysulfide molecules, termed supersulfide, with two or more sulfur atoms catenated in normal hearts, and the supersulfide catabolism in pathologic hearts after myocardial infarction correlated with worsened prognosis of heart failure. However, the impact of supersulfide on myocardial remodeling remains unclear. Here, we investigated the involvement of supersulfide metabolism in cardiomyocyte remodeling, using a model of adenosine 5'-triphosphate (ATP) receptor-stimulated atrophy and endothelin-1 receptor-stimulated hypertrophy in neonatal rat cardiomyocytes. Results revealed contrasting changes in intracellular supersulfide and its catabolite, hydrogen sulfide (H<sub>2</sub>S), between cardiomyocyte atrophy and hypertrophy. Stimulation of cardiomyocytes with ATP decreased supersulfide activity, while H<sub>2</sub>S accumulation itself did not affect cardiomyocyte atrophy. This supersulfide catabolism was also involved in myofibroblast formation of neonatal rat cardiac fibroblasts. Thus, unraveling supersulfide metabolism during myocardial remodeling may lead to the development of novel therapeutic strategies to improve heart failure.

    DOI: 10.1016/j.jphs.2024.05.002

    Web of Science

    Scopus

    PubMed

    researchmap

  • Sulfur metabolism as a new therapeutic target of heart failure. Reviewed

    Nishimura A, Tang X, Zhou L, Ito T, Kato Y, Motohiro Nishida

    Journal of pharmacological sciences   155 ( 3 )   75 - 83   2024.7   ISSN:1347-8613 eISSN:1347-8648

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Sulfur-based redox signaling has long attracted attention as critical mechanisms underlying the development of cardiac diseases and resultant heart failure. Especially, post-translational modifications of cysteine (Cys) thiols in proteins mediate oxidative stress-dependent cardiac remodeling including myocardial hypertrophy, senescence, and interstitial fibrosis. However, we recently revealed the existence of Cys persulfides and Cys polysulfides in cells and tissues, which show higher redox activities than Cys and substantially contribute to redox signaling and energy metabolism. We have established simple evaluation methods that can detect polysulfides in proteins and inorganic polysulfides in cells and revealed that polysulfides abundantly expressed in normal hearts are dramatically catabolized by exposure to ischemic/hypoxic and environmental electrophilic stress, which causes vulnerability of the heart to mechanical load. Accumulation of hydrogen sulfide, a nucleophilic catabolite of persulfides/polysulfides, may lead to reductive stress in ischemic hearts, and perturbation of polysulfide catabolism can improve chronic heart failure after myocardial infarction in mice. This review focuses on the (patho)physiological role of sulfur metabolism in hearts, and proposes that sulfur catabolism during ischemic/hypoxic stress has great potential as a new therapeutic strategy for the treatment of ischemic heart failure.

    DOI: 10.1016/j.jphs.2024.04.005

    Web of Science

    Scopus

    PubMed

    researchmap

  • Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact Reviewed

    Kohei Ariyoshi, Kazuhiro Nishiyama, Yuri Kato, Xinya Mi, Tomoya Ito, Yasu-Taka Azuma, Akiyuki Nishimura, Motohiro Nishida

    International Journal of Molecular Sciences   25 ( 10 )   2024.5   ISSN:1661-6596 eISSN:1422-0067

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/ijms25105446

    Web of Science

    Scopus

    PubMed

    researchmap

  • Supersulfide prevents cigarette smoke extract-induced mitochondria hyperfission and cardiomyocyte early senescence by inhibiting Drp1-filamin complex formation. Reviewed

    Akiyuki Nishimura, Liuchenzi Zhou, Yuri Kato, Xinya Mi, Tomoya Ito, Yuko Ibuki, Yasunari Kanda, Motohiro Nishida

    Journal of pharmacological sciences   154 ( 2 )   127 - 135   2024.2   ISSN:1347-8613 eISSN:1347-8648

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Smoking is one of the most serious risk factors for cardiovascular diseases. Although cigarette mainstream and sidestream smoke are significant contributors to increased cardiovascular mortality and morbidity, the underlying mechanism is still unclear. Here, we report that exposure of rat neonatal cardiomyocytes to cigarette smoke extract (CSE) induces mitochondrial hyperfission-mediated myocardial senescence. CSE leads to mitochondrial fission and reactive oxygen species (ROS) production through the complex formation between mitochondrial fission factor Drp1 and actin-binding protein, filamin A. Pharmacological perturbation of interaction between Drp1 and filamin A by cilnidipine and gene knockdown of Drp1 or filamin A inhibited CSE-induced mitochondrial hyperfission and ROS production as well as myocardial senescence. We previously reported that Drp1 activity is controlled by supersulfide-induced Cys644 polysulfidation. The redox-sensitive Cys644 was critical for CSE-mediated interaction with filamin A. The administration of supersulfide donor, Na2S3 also improved mitochondrial hyperfission-mediated myocardial senescence induced by CSE. Our results suggest the important role of Drp1-filamin A complex formation on cigarette smoke-mediated cardiac risk and the contribution of supersulfide to mitochondrial fission-associated myocardial senescence.

    DOI: 10.1016/j.jphs.2023.12.008

    Web of Science

    Scopus

    PubMed

    researchmap

  • Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data Reviewed

    Laura Fields, Tomoya Ito, Kazuya Kobayashi, Yuki Ichihara, Mihai-Nicolae Podaru, Mohsin Hussain, Kizuku Yamashita, Vanessa Machado, Fiona Lewis-McDougall, Ken Suzuki

    Molecular Therapy   29 ( 8 )   2554 - 2570   2021.8

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ymthe.2021.04.018

  • Cell barrier function of resident peritoneal macrophages in post-operative adhesions Reviewed

    Nature Communications   2021.4

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41467-021-22536-y

  • Modulation of P2Y6R expression exacerbates pressure overload-induced cardiac remodeling in mice Reviewed

    Kakeru Shimoda, Akiyuki Nishimura, Caroline Sunggip, Tomoya Ito, Kazuhiro Nishiyama, Yuri Kato, Tomohiro Tanaka, Hidetoshi Tozaki-Saitoh, Makoto Tsuda, Motohiro Nishida

    Scientific Reports   10 ( 1 )   2020.8

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-020-70956-5

  • Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy Reviewed

    Basic Research in Cardiology   114 ( 5 )   2019.8

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00395-019-0742-1

  • On-site fabrication of Bi-layered adhesive mesenchymal stromal cell-dressings for the treatment of heart failure Reviewed

    Kazuya Kobayashi, Yuki Ichihara, Nobuhiko Sato, Nobuyoshi Umeda, Laura Fields, Masafumi Fukumitsu, Yoshiyuki Tago, Tomoya Ito, Satoshi Kainuma, Mihai Podaru, Fiona Lewis-McDougall, Kenichi Yamahara, Rakesh Uppal, Ken Suzuki

    Biomaterials   209   41 - 53   2019.7

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.biomaterials.2019.04.014

  • Fibrin Glue-aided, Instant Epicardial Placement Enhances the Efficacy of Mesenchymal Stromal Cell-Based Therapy for Heart Failure Reviewed

    Kazuya Kobayashi, Yuki Ichihara, Nobuko Tano, Laura Fields, Nilaani Murugesu, Tomoya Ito, Chiho Ikebe, Fiona Lewis, Kenta Yashiro, Yasunori Shintani, Rakesh Uppal, Ken Suzuki

    Scientific Reports   8 ( 1 )   2018.6

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-018-27881-5

  • TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy Reviewed

    Tsukasa Shimauchi, Takuro Numaga-Tomita, Tomoya Ito, Akiyuki Nishimura, Ryosuke Matsukane, Sayaka Oda, Sumio Hoka, Tomomi Ide, Norimichi Koitabashi, Koji Uchida, Hideki Sumimoto, Yasuo Mori, Motohiro Nishida

    JCI Insight   2 ( 15 )   2017.8

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1172/jci.insight.93358

  • IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice Reviewed

    Yusuke Shintani, Tomoya Ito, Laura Fields, Manabu Shiraishi, Yuki Ichihara, Nobuhiko Sato, Mihai Podaru, Satoshi Kainuma, Hiroyuki Tanaka, Ken Suzuki

    Scientific Reports   7 ( 1 )   2017.7

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-017-07328-z

  • Genes that integrate multiple adipogenic signaling pathways in human mesenchymal stem cells Reviewed

    Tomoya Ito, So Tsuruta, Koki Tomita, Kunio Kikuchi, Takahide Yokoi, Yasunori Aizawa

    Biochemical and Biophysical Research Communications   409 ( 4 )   786 - 791   2011.6

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2011.05.089

  • Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation Reviewed

    Kunio Kikuchi, Makiha Fukuda, Tomoya Ito, Mitsuko Inoue, Takahide Yokoi, Suenori Chiku, Toutai Mitsuyama, Kiyoshi Asai, Tetsuro Hirose, Yasunori Aizawa

    Nucleic Acids Research   37 ( 15 )   4987 - 5000   2009.6

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/nar/gkp426

▼display all

MISC